CASI Pharmaceuticals Newsroom

CASI Pharmaceuticals Analyst Ratings

BenzingaMay 15, 2024 11:47 ET

CASI Pharmaceuticals Analyst Ratings

BenzingaNov 15, 2023 07:39 ET

HC Wainwright & Co. Reiterates Buy on CASI Pharmaceuticals, Maintains $10 Price Target

BenzingaAug 14, 2023 06:36 ET

CASI Pharmaceuticals Analyst Ratings

BenzingaAug 14, 2023 06:35 ET

Analysts Are Bullish on Top Healthcare Stocks: CASI Pharmaceuticals (CASI), Mirum Pharmaceuticals (MIRM)

TipRanksMay 22, 2023 06:30 ET

HC Wainwright & Co. Reiterates Buy on CASI Pharmaceuticals, Maintains $10 Price Target

BenzingaMay 22, 2023 06:17 ET

Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX), CASI Pharmaceuticals (CASI) and CVRx (CVRX)

TipRanksApr 28, 2023 09:08 ET

CASI Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsNov 16, 2022 08:28 ET

BTIG Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $10

Benzinga Real-time NewsNov 16, 2022 08:28 ET

CASI Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsNov 15, 2022 06:19 ET

HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Lowers Price Target to $10

Benzinga Real-time NewsNov 15, 2022 06:18 ET

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), CASI Pharmaceuticals (CASI) and Inhibikase Therapeutics (IKT)

TipRanksAug 15, 2022 11:10 ET

CASI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesAug 15, 2022 10:39 ET

CASI Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsAug 15, 2022 10:28 ET

Analysts' Top Healthcare Picks: CASI Pharmaceuticals (CASI), Mereo Biopharma Group Plc (MREO)

TipRanksJun 3, 2022 13:54 ET

BTIG Raises CASI Pharmaceuticals' Price Target to $21 From $40, Buy Rating Kept

MT NewswiresJun 3, 2022 09:38 ET

CASI Pharmaceuticals Is Maintained at Buy by BTIG

Dow JonesJun 3, 2022 09:11 ET

BTIG Maintains Buy on CASI Pharmaceuticals. Adjusts price target to $21

Benzinga Real-time NewsJun 3, 2022 09:06 ET

CASI Pharmaceuticals analyst ratings

Benzinga Analyst RatingsJun 3, 2022 09:04 ET